Max Chat
Shanghai Bio-heart Biological Technology Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 118.32 | -100% | 0 | 0% |
| P/S |
|
0 | 16.05 | -100% |
|
|
| P/BV |
|
1.05 | 5.73 | -81.67% |
|
|
| P/FCF |
|
0 | 28.9 | -100% |
|
|
| Ev/Ebitda |
|
-2.58 | 16.62 | -115.52% |
|
|
| Ev/S |
|
0 | 17.13 | -100% |
|
|
| Ev/FCF |
|
0 | 26.49 | -100% |
|
|
| E/P |
|
-0.2022 | 0.0239 | -945.31% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
0 | -47.67 | -100% | 0 | 0% |
| ROE |
|
-23.68 | 2.65 | -994.07% |
|
|
| ROA |
|
-15.04 | 3.24 | -564.66% |
|
|
| ROIC |
|
0 | 0 | 0% |
|
|
| ROS |
|
0 | -59.32 | -100% |
|
|
| ROCE |
|
0 | 1.66 | -100% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.0763 | 0.5881 | -112.97% | -0.0763 | 0% |
| Nеt Debt/Ebitda |
|
0 | -0.1844 | -100% |
|
|
| Debt/Ratio |
|
0 | 0.1106 | -100% |
|
|
| Debt/Equity |
|
0 | 0.9261 | -100% |
|
|
| Debt/Net Income |
|
-0.0886 | 5.27 | -101.68% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.3202 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 1.05 | -100% | ||
| DSI |
|
0 | 0.6806 | -100% |
|
|
| Average dividend growth |
|
0 | -1.23 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 1.28 | -100% |
|
|
| Average percentage for payments |
|
0 | 87.72 | -100% |
|
|
| Difference from average difference in sector |
|
-0.3202 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
0/10
|
0 | 26.24 | -100% | ||
| Growth impulse Ebitda in 5 years |
|
0 | 12.85 | -100% | ||
| Growth impulse Net Income in 5 years |
|
0 | 309.26 | -100% | ||
| Growth impulse FCF in 5 years |
|
0 | 45.01 | -100% | ||
| Growth impulse EPS in 5 years |
|
0 | 18.38 | -100% |
IP Score
2.73/10
